The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease

The emerging role of MET/HGF inhibitors in oncology

(2013) Giorgio V. Scagliotti et al.   CANCER TREATMENT REVIEWS

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins

(2013) J. Remon et al.   CANCER TREATMENT REVIEWS

Development and Characteristics of Preclinical Experimental Models for the Research of Rare Neuroendocrine Bladder Cancer

(2013) Thomas Hofner et al.   JOURNAL OF UROLOGY

MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met

(2013) Xin Xu et al.   MOLECULES AND CELLS

Challenging current paradigms

(2013) Aidan P. Noon et al.   Nature Reviews Urology

Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial

(2012) David C. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

MET: a promising anticancer therapeutic target

(2012) Solange Peters et al.   Nature Reviews Clinical Oncology

Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer

(2011) Chen-Yun Yeh et al.   BMC CANCER

An hTERT-immortalized human urothelial cell line that responds to anti-proliferative factor

(2010) Jayoung Kim et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase–2 and –7 and E-cadherin

(2009) Yasuyoshi Miyata et al.   HUMAN PATHOLOGY

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

(2008) Marko Babjuk et al.   EUROPEAN UROLOGY

Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells

(2008) Tom Donnem et al.   Journal of Thoracic Oncology

Prognostic Value of MET, RON and Histoprognostic Factors for Urothelial Carcinoma in the Upper Urinary Tract

(2008) E. Compérat et al.   JOURNAL OF UROLOGY

EGFR Antagonists in Cancer Treatment

(2008) Fortunato Ciardiello et al.   NEW ENGLAND JOURNAL OF MEDICINE